Founded in 1999 KineMed is a privately held biotechnology company based in Emeryville, CA, is a leader in translational and personalized medicine. KineMed, Inc. is a drug discovery and development company employing its proprietary translational medicine technology (AquaTag™ and KineMarker™) to both identify active drug candidates preclinically and confirm their therapeutic activity and dose response in first-in-man studies. The Company is working to develop drugs both on its own and with pharmaceutical collaborators in therapeutic focus areas where it can demonstrate functional modulation of specific biological pathways that mediate disease. KineMed's technology expedites the drug development process and provides real-time insight into conditions including metabolic disorders, cancer, fibrotic diseases, inflammation, and neurodegeneration.